ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U.

ISRG lows -2.6% and MDT -0.5% after earlier JNJ announced the FDA authorization for its Ottava Surgical Robot, marking its entry into the U.S. robotic soft-tissue Surgery market